SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IVAX Insider Trading -- Ignore unavailable to you. Want to Upgrade?


To: 5,17,37,5,101,... who wrote (490)1/26/1998 6:39:00 AM
From: flickerful  Respond to of 756
 
ivax is now a buy here:

suretrade.stkwtch.com

the first time i have seen that...



To: 5,17,37,5,101,... who wrote (490)1/26/1998 6:54:00 AM
From: flickerful  Respond to of 756
 
as i expected,
guess who is a cnbc
darling this morning
on stocks to watch...
right out of bloomberg's equity preview.

you got it.



To: 5,17,37,5,101,... who wrote (490)1/26/1998 2:00:00 PM
From: flickerful  Read Replies (1) | Respond to of 756
 
ok, i give up.
to coin a phrase:
what do they know,
and when did they know it?
what is with the pr bs, the trading et al...
an attempt to prop us up pre-earnings?

what is with the "lengthy restructuring"
of which we know precious little. what was
the problem with the gel-cap deal.....oh brother.
why do i even ask; they certainly won't divulge
anything of substance.

Drugs/Device Market Comment, Indexes
Excerpted from Federal Filings Business News, a real time news wire

Januaury 20, 1998

Stocks Soar 2.1%, End Week Up 4.7%

Only Ivax Corp. (IVX), which is in the middle of a lengthy restructuring effort, is expected to turn in a poor performance for the quarter, says Dow Jones News. Analysts estimate the Miami company's losses widened to 34 cents a share from 2 cents in fourth quarter 1996, according to First Call...